Autocrine BMP4 signaling involves effect of cholesterol myristate on proliferation of mesenchymal stem cells

Steroids

Volumn 74, Issue 13-14, 2009, Pages 1066-1072

  Chen, Dong Feng ^a,c   Du, Shao Hui ^a   Zhang, Hai Ling ^a   Li, Hui ^a   Zhou, Jian Hong ^a   Li, Yi Wei ^a   Yi, Xiang Hua ^a   Hou, Qiu Ke ^a   Wu, Jing ^a   Zeng, He Ping ^b   Hua, Zi Chun ^c  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

Autocrine bone morphogenetic protein signaling; Cholesterol myristate; Mesenchymal stem cell; Proliferation

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CHOLESTEROL MYRISTATE; HERBACEOUS AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, NEUTRALIZING; AUTOCRINE COMMUNICATION; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CARRIER PROTEINS; CELL PROLIFERATION; CHOLESTEROL ESTERS; MESENCHYMAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 70350564282     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.08.008     Document Type: Article

References (25)

1. Pennisi E. Neural beginnings for the turtle's shell. Science 303 (2004) 951
2. The state pharmacopoeia Commission of the People's Republic of China. Carapax et Plastrum testudinis (2000), Pharmacopoeia of the People's Republic of China pp. 15-16 [English edition]
3. Chen D.F., Zeng H.P., Du S.H., Li H., Zhou J.H., Li Y.W., et al. Extracts from Plastrum testudinis promotes proliferation of rat bone-marrow derived mesenchymal stem cells. Cell Prolif 40 (2007) 196-212
4. Chen W., Zeng H.P., Wang C.Y., Wang T.T., and Chen D.F. Experimental investigation of chemical components in the extracts from Plastrum testudinis induce proliferation of rat-mesenchymal stem cell (rMSCS). Acta Chim Sin 65 (2007) 265-270
5. Zhang Y.H., Zeng H.P., and Chen D.F. Effect of fatty acids methyl ester from Plastrum testudin is on proliferation of rat bone mesenchymal stem cell. Chin J Anal Chem 35 (2007) 1400-1404
6. Diefenderfer D.L., Osylzka A.M., Reilly G.C., and Leboy P.S. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res 44 Suppl. 1 (2003) 305-311
7. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10 (1996) 1580-1594
8. Urist M.R. Bone morphogenetic protein: the molecularization of skeletal system development. J Bone Miner Res 12 (1997) 332-342
9. Akino K., Mineta T., Fukui M., Fujii T., and Akita S. Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Repair Regen 11 (2003) 354-360
10. Ogata T., Wozney J.M., Benezra R., and Noda M. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation or inhibitor of DNA binding), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci 90 (1993) 19-22
11. Heldin C.H., Miyazono K., and Dijke P.T. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
12. Kawabata M., Imamura T., and Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9 (1998) 49-61
13. Conget P.A., and Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cell. J Cell Physiol 181 (1999) 67-73
14. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
15. Ogston N., Harrison A.J., Cheung H.F., Ashton B.A., and Hampson G. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Steroids 67 (2002) 895-906
16. Helvering L.M., Sharp R.L., Ou X.M., and Geiser A.G. Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes. Gene 256 (2000) 123-138
17. Thompson D.L., Gerlach-Bank L.M., Barald K.F., and Koenig R.J. Retinoic acid repression of bone morphogenetic protein 4 in inner ear development. Mol Cell Biol 23 (2003) 2277-2286
18. Natsume T., Tomita S., Iemura S., Kinto N., Yamaguchi A., and Ueno N. Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4. J Biol Chem 272 (1997) 11535-11540
19. Yeh L.C., Adamo M.L., Olson M.S., and Lee J.C. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 138 (1997) 4181-4190
20. Lecanda F., Avioli L.V., and Cheng S.-L. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 67 (1997) 386-398
21. Gerlach L.M., Hutson M.R., Germiller J.A., Nguyen-Luu D., Victor J.C., and Barald K.F. Addition of the BMP4 antagonist, noggin, disrupts avian inner ear development. Development 127 (2000) 45-54
22. Takeda M., Otsuka F., Nakamura K., Inagaki K., Suzuki J., Miura D., et al. Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action. Endocrinology 145 (2004) 4344-4354
23. Bostrom M.P., Lane J.M., Berberian W.S., Missri A.A., Tomin E., Weiland A., et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13 (1995) 357-367
24. Urist M.R., Hudak R.T., Huo Y.K., and Rasmussen J.K. Osteoporosis: a bone morphogenetic protein auto-immune disorder. Prog Clin Biol Res 187 (1985) 77-96
25. Wang E.A. Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects. Trends Biotechnol 1 (1993) 379-383